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Abstract. Glutamate (glu) an excitatory neurotransmitter amino acid, is present in high concentrations in the 
mammalian central nervous ystem and is the most abundant amino acid in our daily diet. In the present study the 
activities of lactate dehydrogenase (LDH) and glutamate dehydrogenase (GDH) were evaluated in the circumven- 
tricular organs (CVO) of the brain in 25-day-01d rats following MSG administration at a dose of 4 mg/g b.wt 
during the first ten days of life. The results show the LDH activity increased to 265% of that in the control 
(p <0.001), whereas GDH activity was significantly decreased (p <0.05), The great elevation in LDH, a 
cytoplasmic marker enzyme, is apparently due to cytoskeletal changes brought about as a consequence of glu 
toxicity, whereas lowered GDH activity indicates altered g!u homostasis n the blood-brain-barrier deficient areas 
following neonatal exposure to glu. 
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Evidence now exists for the neurotoxic actions of gluta- 
mate (glu), an excitatory transmitter and the most 
abundant amino acid in the mammalian brain l'a3 as 
well as in most dietary proteins 4.It has also been shown 
that several structural analogs of glu possess both neu- 
roexcitatory and neurotoxic properties, and these have 
therefore been called excitotoxins 5'6'7. Moreover, recent 
reports including our own indicate a generalized efect 
in glu metabolism in patients with motor neuron dis- 
eases a,9. Monosodium glutamate (MSG), the sodium 
salt of glu, has been shown to cause lesions in the 
developing brain of several animal species following its 
oral or systemic application in excessive amounts during 
the neonatal period 6, 7. The brain damage resulting from 
peripheral glu is selective for certain brain regions 
which are collectively known as circumventricular o - 
gans (CVO). The blood-brain barrier (BBB) is deficient 
in these areas, owing to anatomical peculiarities 1~ 
Most of the earlier studies focused on ultrastructural or
neuroendocrine changes caused by systemic glu adminis- 
tration 7. The present study was designed to evaluate 
some biochemical mechanisms ofglu toxicity by measur- 
ing the activities of lactate dehydrogenase (LDH), a 
cytoplasmic enzyme marker, and glutamate dehydroge- 
nase (GDH), a key enzyme ofglu metabolism, in organs 
of the CVOI including the arcuate hypothalamus-median 
eminence (AH-ME), following neonatal exposure of rats 
of MSG. 
Materials and methods 
Animals and housing. Adult Wistar rats weighing 200- 
250 g were housed under controlled conditions of light 
(12 h light: 12 h dark) and temperature 22 _+ 2 ~ They 
were fed with rat pellets (Lipton, India) and tap water 
ad libitum. Males of proven fertility and sexually ma- 
ture females were allowed to cohabit. Presence of sperm 
in the vaginal smear was taken as day 1 of pregnancy. 
Mated rats were left in individual cages until term. The 
litter size was adjusted to 8 uniformly by redistribution 
among mothers which had delivered within a span of 2 
days. Litters from each rat were divided into two 
groups, control and experimental. MSG was obtained 
from Sigma Chemical Co., USA, and administered to 
the pups by subcutaneous injection at a dose of 4 rag/ 
g b.wt during the first ten days of the postnatal period. 
This dose had earlier been shown to produce neuroen- 
docrine ablations in rats 7. It was 100 to 1000 times 
higher than the daily per capita intake of MSG, world 
wide 4. An equal volume of physiological saline was 
given to control animals. 
Pups were sacrificed on day 25 by cervical dislocation 
and the brains rapidly dissected out on a cold tray. The 
midbrain region, which included the circumventricular 
organs: the AH-ME, the organum vasculosum of the 
lamina terminalis, the subfornical organ and the sub- 
commisural organ, were dissected out. A piece of fron- 
tal cortex was used as tissue control. Tissues were 
homogenized in 10% w/v 0.32M sucrose and cen- 
trifuged as 12000 RPM for 20 rain, and the supernatant 
was used as enzyme source. LDH was assayed 1l by 
determining the rate of oxidation of NADH in the 
presence of buffered substrate, i.e. pyruvate, which is 
converted to lactate. The 3 ml reaction medium con- 
tained 0.1 ml supernatant, 2.9 ml 0.01 M sodium pyru- 
vate in 0.1 M phosphate buffer and 0.1 ml 3.5 gmoles 
NADH. The reaction was initiated by rapidly adding 
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pyruvate and transferring the contents into a cuvette. 
The  reduced coenzyme (NADH) absorbs strongly at 
340 nm while the oxidized form (NAD) does not, so the 
progress of the reaction could be monitored by measur- 
ing the decrease in extinction at 340 nm for 2 min at 
25 ~ 
GDH was assayed 12 using the same principle. The 3 ml 
reaction medium contained 0.1 ml enzyme extract pre- 
treated with Triton X-100, l ml 100 gmoles Tris con- 
taining 30 pmoles EDTA, 1 ml 300 gmoles (NH4)2SO4, 
0.4 ml 0.1 p, moles NADH and 0.5 ml 20 gmoles 2-oxo- 
glutarate. The reaction was initiated by the addition of 
2-oxoglutarate while the blank contained no 2-oxoglu- 
tarate. GDH catalyses the reversible oxidative deamina- 
tion of glutamate to 2-oxoglutarate. The enzyme 
activities were expressed as n-moles NADH oxidized/ 
rain/rag protein. Protein was estimated by the method 
of Lowry et al.~3. 
Results 
The table indicates the levels of LDH and GDH in the 
CVO of 25-day-old rats following MSG treatment. It
can be seen that the activity of LDH significantly in- 
creased ( +265%, p < 0.001) in the MSG-treated group 
with respect o the saline-treated controls, whereas the 
activity of GDH was significantly decreased ( -  19%, 
p <0.05) in the BBB-deficient areas of MSG-treated 
animals as compared to the. control group. No signifi- 
cant alterations in the above parameters in MSG 
treated rats in comparison to saline-injected animals 
were observed in the frontal cortex (data not shown). 
Discussion 
The present study indicates that neonatal MSG expo- 
sure in rats significantly increased the activity of LDH, 
whereas GDH activity was decreased in the CVO. LDH 
is an important enzyme regulating energy metabolism in
the cell, and is also known to be a cytoplasmic enzyme 
marker. The large increase in this enzyme activity im- 
plies that MSH causes altered plasma membrane perme- 
ability, and consequent cellular damage. An earlier 
report 14 showed that LDH leaks from the slice into the 
medium when sagittat slices of brain are incubated with 
various glutamate agonists, indicating that these excito- 
toxins bring about rupture of neuronal plasma mem- 
branes. Our in vivo finding corroborates this in vitro 
report. At low pH caused by lactic acidosis there is 
denaturation of structural and integral proteins, which 
might be responsible for disruption of neuronal plasma 
membranes15. 
The activity of GDH, a key enzyme of glu metabolism, 
is decreased. This suggests that neonatal MSG treat- 
ment caused alterations in glu homeostasis in these 
brain areas. Depending upon several factors, GDH 
can catalyze glutamate breakdown or formation t6. 
Disturbances in brain glu metabolism were reported 
earlier during excessive neuronal activity, e.g. convul- 
sions 17, and also under conditions of ischemia/ 
hypoxia ix. Common to both is a decline in the energy 
level of the brain and a reduction in transmembrane ion
gradients, which may result ultimately in the reductive 
amination of 2-0xo glutarate and the formation of glu. 
The decreased activity of GDH in the present study 
indicates that oxidative deamination is reduced. This 
finding is in agreement with an earlier report 19 showing 
increased tissue levels of glu in AH-ME following 
neonatal MSG treatment. It was also shown 2~ that in 
patients with recessive, adult-onset olivo-ponto-cerebral 
degeneration associated with a partial GDH deficiency, 
plasma glutamate rises. Furthermore, in this disease 
state, decreased catabolism of glutamate at the nerve 
terminals results in an increased retention in the synap- 
tic cleft of the amino acid released during neuronal 
activity. This, in turn, could cause direct damage to 
post-synaptic neurons. These data also strongly support 
the view that in vivo GDH is intimately involved in 
glutamate disposal. 
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Table. LDH and GDH activities in the CVO of day 25 rats following neonatal MSG application. All values represent mean • SEM. 
Student's t' test was used to evaluate statistical significance. A 'p' value less than 0.05 was considered significant. 
Enzyme Units Control Treated % increased (+) or p value 
% decreased ( - )  vs 
vs control control 
LDH 
GDH 
n moles NADH 350 • 40 930 • 50 +265% <0.001 
oxidized/min/ (6) (6) 
nag protein 
n moles NADH 2090 • 190 1700 • 90 - 19% <0.05 
oxidized/rain/ (6) (6) 
mg protein 
Numbers in parentheses indicate the number of animals in each group. 
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